March 14 Deadline Alert: Law Offices of Howard G. Smith Reminds Esperion Therapeutics, Inc. Investors of Upcoming Lead Plaint...
March 11 2016 - 9:30AM
Business Wire
Law Offices of Howard G. Smith reminds investors of the
upcoming March 14, 2016 deadline to file a lead
plaintiff motion in the class action filed on behalf of investors
who purchased Esperion Therapeutics, Inc. (“Esperion” or the
“Company”) (NASDAQ: ESPR) securities between August 18, 2015 and
September 28, 2015, inclusive (the “Class Period”). Investors
who suffered losses on their investment in Esperion securities are
encouraged to contact the Law Offices of Howard G. Smith to discuss
their legal rights.
The complaint alleges that throughout the Class Period,
Defendants made materially false and misleading statements
regarding Esperion's business and prospects to shareholders,
including that there was no clear path to approval for ETC-1002,
that the FDA had encouraged Esperion to initiate a cardiovascular
outcomes trial ("CVOT") and that completion of a CVOT could be
necessary prior to approval of ETC-1002. Upon disclosure that the
Company would need to perform additional CVOTs prior to approval,
shares of Esperion fell dramatically, over $16 per share, or nearly
50%, to close on September 29, 2015 at $18.33 per share.
If you purchased Esperion shares, you may move the Court no
later than March 14, 2016 to request appointment
as lead plaintiff. To be a member of the class you need not take
any action at this time; you may retain counsel of your choice or
take no action and remain an absent member of the Class. If you
wish to learn more about this action, or if you have any
questions concerning this announcement or your rights or interests
with respect to these matters, please contact Howard G. Smith,
Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike,
Suite 112, Bensalem, Pennsylvania 19020 by telephone at (215)
638-4847, toll-free at (888) 638-4847, or by e-mail
to howardsmith@howardsmithlaw.com, or visit our website
at http://www.howardsmithlaw.com.
This press release may be considered Attorney Advertising in
some jurisdictions under the applicable law and ethical rules.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160311005127/en/
Law Offices of Howard G. SmithHoward G. Smith,
Esquire215-638-4847888-638-4847howardsmith@howardsmithlaw.comwww.howardsmithlaw.com
Esperion Therapeutics (NASDAQ:ESPR)
Historical Stock Chart
From Jun 2024 to Jul 2024
Esperion Therapeutics (NASDAQ:ESPR)
Historical Stock Chart
From Jul 2023 to Jul 2024